SGK1 and Parkinson disease: In glial cells, inhibition of SGK1 was shown to correct the pro-inflammatory properties of glial cells by inhibiting the inflammatory pathways mediated by the intracellular NF-κB signaling pathway, NLRP3-inflammatory vesicles, and the CGAS-STING signaling pathway, which in turn alleviated the symptoms of PD.